Browsing Tag
Biohaven Ltd.
6 posts
Biohaven (NYSE: BHVN) deprioritizes BHV-7000 in depression after Phase 2 miss, shifts focus to epilepsy, obesity, and immunology
Biohaven ends BHV-7000 depression trials after Phase 2 miss. Find out why it's shifting R&D focus to epilepsy, obesity, and immunology in 2026.
Wall Street winners: Pony AI, ADMA Biologics, Luckin Coffee among top gainers
Find out which stocks led Wall Street on April 29, 2025, and why economic turbulence could shape their next moves. See the full list of today's biggest gainers.
Saia, BioNTech, and AppFolio stocks plunge amid trade war fallout
Explore why top U.S. stocks crashed on April 25, 2025, as tariffs, recession risks, and institutional selloffs rattled Wall Street. Read full sector analysis.
Top stock market trends – Eli Lilly jumps $105, Hertz explodes 44%, Trump Media rallies again
Explore why Hertz, Eli Lilly, and Trump Media led the top U.S. stock market gainers on April 17, 2025. Get key data, economic context, and investor insights now.
US stock market declines as Vaxcyte, Biohaven, and Moderna lead losses
US stocks closed sharply lower on March 31, 2025, led by biotech and tech losses. Learn why markets are reacting to tariffs, interest rates, and economic uncertainty.
Merus and Biohaven partner to co-develop bispecific ADC therapies
Merus N.V. and Biohaven Ltd. have announced a strategic collaboration to advance the development of three bispecific antibody-drug…